Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse model

Published:2016-04-19 Issue:8-9 Volume:23 Page:657-663
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Hou X,Jiao R,Guo X,Wang T,Chen P,Wang D,Chen Y,He C-Y,Chen Z-Y

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201637.pdf

Reference33 articles.

1. Brown MS, Goldstein JL . Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci USA 1974; 71: 788–792.

2. Van Craeyveld E, Jacobs F, Gordts SC, De Geest B . Gene therapy for familial hypercholesterolemia. Curr Pharm Des 2011; 17: 2575–2591.

3. Soutar AK, Naoumova RP . Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 2007; 4: 214–225.

4. Apstein CS, Zilversmit DB, Lees RS, George PK . Effect of intessive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia. Atherosclerosis 1978; 31: 105–115.

5. Leonard JV, Clarke M, Macartney FJ, Slack J . Progression of atheroma in homozygous familial hypercholesterolaemia during regular plasma exchange. Lancet 1981; 2: 811.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New opportunities in the management and treatment of refractory hypercholesterolemia using in vivo CRISPR-mediated genome/base editing;Nutrition, Metabolism and Cardiovascular Diseases;2023-12

2. A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD;Cells;2023-06-16

3. Gene and cell therapy approaches for familial hypercholesterolemia: An update;Drug Discovery Today;2023-03

4. Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-09

5. The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy;Frontiers in Genetics;2022-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3